Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,128 | 47,875 | 119,758 | 151,404 | 66,805 |
| Marketable Securities | 174,871 | 199,381 | 24,561 | 15,379 | 31,949 |
| Receivables | 54,463 | 20,260 | 17,696 | 19,431 | 8,460 |
| Inventories | 1,564 | 1,873 | 1,218 | 182 | N/A |
| TOTAL | $287,026 | $269,389 | $163,233 | $186,395 | $112,825 |
| Non-Current Assets | |||||
| PPE Net | 6,839 | 7,133 | 6,978 | 7,155 | 8,477 |
| Investments And Advances | 3,059 | 3,408 | 3,335 | 5,359 | 7,089 |
| Intangibles | 1,291 | 0 | 0 | 0 | 342 |
| Other Non-Current Assets | 19,409 | 19,528 | 19,621 | 19,128 | 18,962 |
| TOTAL | $30,597 | $30,069 | $29,935 | $31,641 | $34,870 |
| Total Assets | $317,624 | $299,458 | $193,167 | $218,037 | $147,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,427 | 27,222 | 19,548 | 25,596 | 4,892 |
| Other current liabilities | N/A | N/A | N/A | N/A | 21,481 |
| TOTAL | $37,613 | $29,382 | $21,685 | $27,682 | $30,568 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 56,584 | 56,831 | 49,861 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,178 |
| Other Non-Current Liabilities | 14,758 | 17,697 | 17,885 | 17,991 | 17,687 |
| TOTAL | $14,758 | $17,697 | $74,468 | $74,822 | $67,547 |
| Total Liabilities | $52,372 | $47,080 | $96,153 | $102,504 | $98,115 |
| Shareholders' Equity | |||||
| Common Shares | 8,567 | 8,568 | 7,494 | 7,321 | 6,297 |
| Retained earnings | 255,037 | 241,126 | 86,868 | 106,142 | 40,776 |
| Other shareholders' equity | 1,649 | 2,685 | 2,652 | 2,070 | 2,507 |
| TOTAL | $265,252 | $252,378 | $97,014 | $115,533 | $49,579 |
| Total Liabilities And Equity | $317,624 | $299,458 | $193,167 | $218,037 | $147,695 |